Lawlor accepts two-year USADA suspension

February 25, 2017

UFC’s Tom Lawlor has accepted a two-year suspension from USADA after a positive out-of-competition test for the banned substance ostarine.  Lawlor will be out until October 10, 2018.

The out of competition test took place on October 10, 2016.

Lawlor, 33, did not make a formal attempt to appeal the flagged test which put him on provisional suspension.

Via the USADA release:

Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) which is illegally sold in the United States and globally as a performance-enhancing substance. Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects. Nonetheless, ostarine has been found as a declared and undeclared ingredient in many dietary supplements sold in the United States, which has prompted the U. S. Food and Drug Administration (FDA) to issue warning letters to specific dietary supplement manufacturers stating that ostarine is an unapproved new drug and that selling the drug is in violation of the Federal Food, Drug, and Cosmetic Act (FDCA).

Lawlor responded to the two year suspension on twitter with his lab results:

Payout Perspective:

It’s a tough suspension for the popular 33-year-old although it seems that he may be embarking on a pro wrestling career.  Without a formal appeal, it might seem that despite the levels found in his test were low, the probability of a successful appeal was as low.

Got something to say?

You must be logged in to post a comment.